‹ Screener

Glass House Brands Inc.

GLASF · Medicinal Chemicals & Botanical Products · EDGAR filings ↗

Reference price $10.48 — last insider sale, 2026-05-26 (estimated from the dated SEC Form 4 price — not a live quote)

Grade

D50

Loss-making cannabis grower with declining revenue, high leverage and a disclosed material weakness in internal controls.

Strengths

Risks

Notable findings

Key metrics

Gross margin
42.3%
Operating margin
-9.1%
Net margin
-16.3%
Return on equity
-40.1%
Return on assets
-9.3%
ROIC
-9.2%
Revenue growth (QoQ)
-9.4%
Debt / equity
0.9×
Current ratio
1.8×
Free cash flow
-$16M
EBITDA
-$2M
Tangible book value
$62M
Stock comp / revenue
7.4%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-03Tu WilliamTax withheld2.0K$11.37
2026-06-01Tu WilliamOption exercise5.8K
2026-05-26Tu WilliamSell5.4K$10.48
2026-05-22Tu WilliamSell10K$10.19
2026-05-22Tu WilliamTax withheld2.9K$10.29
2026-05-19Tu WilliamSell16K$10.08
2026-05-18Tu WilliamOption exercise8.3K

All non-derivative Form 4 activity (SEC), newest first.

Recent filings

FormFiledPeriodAccession
40-F2026-03-242025-12-310001848731-26-000015 ↗
40-F2025-03-252024-12-310001848731-25-000007 ↗
40-F2024-04-012023-12-310001104659-24-041973 ↗
40-F2023-03-312022-12-310001104659-23-040286 ↗
20-F2022-12-302021-06-290001104659-22-131139 ↗
40-F2022-03-222021-12-310001104659-22-036647 ↗